FMFinlay Maguire

Finlay Maguire

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Finlay Maguire has a total of 357 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Analysing antimicrobial resistance mobility patterns using a diverse dataset of over 8000 bacterial species

    by Baofeng Jia, Brian P. Alcock, Amogelang R. Raphenya, Jason Spence, Finlay Maguire, Robert G. Beiko, Andrew G. McArthur, Claire Bertelli, Fiona S.L. Brinkman

    Advances in genomics have enhanced surveillance of antimicrobial resistance (AMR), yet the factors governing resistance gene mobility, and therefore their risk of spread, remain poorly characterized. Here, we analyzed AMR gene distributions across thousands of bacterial genomes from NCBI RefSeq, encompassing clinical, agricultural and environmental isolates, to quantify associations with plasmids and predicted mobile genomic islands. AMR genes were identified using the Resistance Gene Identifier, and in addition to plasmid identification, mobile chromosomal elements were predicted using IslandViewer 4. Analysing both the full dataset and subsets of data with corrections for sampling bias, we show that known AMR genes are significantly enriched in mobile regions overall. However, stratification by resistance mechanism supported marked heterogeneity: certain drug classes and mechanisms are strongly associated with mobile elements, whereas others are predominantly chromosomal and non-mobile. Notably, mechanisms with specialized functions showed higher mobility, consistent with their role as “ecological public goods” that need not be present in all cells to confer community-level benefit. Differences were also observed across bacteria with distinct cell envelope structures. Together, these findings lay the groundwork for predictive models of AMR gene mobility and provide a framework for incorporating gene-level mobility into AMR risk assessment and antimicrobial stewardship policy.

  • Open Access

    Influenza A virus H5Nx genotypes assigned by genetic similarity are incongruent with global phylogenies

    by Angela McLaughlin, Hoc Tran, Deanna Tait, Hoang-Hai Nguyen, Josip Rudar, Jolene A. Giacinti, Anthony V. Signore, Oliver A. Lung, Yohannes Berhane, Zvonimir Poljak, et al.

    Influenza A virus H5N1 and related subtypes (H5Nx) have broad host ranges and pose a pandemic risk. Since early 2022, H5 clade 2.3.4.4b has predominated globally, causing unprecedented mortality in wild birds, poultry, and mammals, with spillovers to humans. Accurate viral classification is essential for tracking H5Nx variant emergence and spread, but reassortment among genome segments with distinct evolutionary histories complicates genotyping. H5Nx genotype assignment tools, GenoFlu in North America and Genin2 in Europe, assign segments to clusters by genetic similarity to reference sequences and define genotypes as constellations of segment clusters. However, genetic similarity does not necessarily imply recent shared ancestry due to independently re-occurring mutations and variability in the evolutionary rate. Furthermore, similarity is defined relative to references that may inadequately represent diversity. We evaluated the congruence of genetic similarity-based H5Nx clusters and genotypes with phylogenies of global sequences across eight segments. H5Nx genomes from 41,366 samples were assigned GenoFlu and Genin2 genotypes, and maximum likelihood phylogenies were inferred for each segment. CD-HIT and phylogenetic TreeCluster clusters were also generated for a range of distance thresholds. Clustering methods were evaluated based on phylogenetic purity, monophyly, and diversity. Reassortment within predominant GenoFlu and Genin2 genotypes was evaluated based on their phylogenetic cluster spans. Expectedly, GenoFlu was largely unable to assign genomes from outside of North America, South America, and Antarctica from 2022 to 2025, whereas Genin2 assignments struggled outside of Europe, Africa, and Western Asia. Only 14.2% of GenoFlu clusters were monophyletic, while Genin2 clusters were more variable across segments (overall 49.3% monophyletic). Despite CD-HIT yielding genetic distance clusters of similar size to TreeCluster, they were less monophyletic (44%) and encompassed greater phylogenetic diversity. We identified several genotypes, such as GenoFlu B3.13, D1.1, and D1.3, with segments that had diversified into separate subclusters. Similarly, GenoFlu genotypes B3.5 and A3, and Genin2 genotypes EA-2020-C, EA-2021-AB, and EA-2022-CH may erroneously combine multiple distinct reassortants. Genetic similarity-based H5Nx genotyping tools are rapid, stable, and sufficient for broad categorization, but may group viruses with distinct evolutionary histories and fail to assign divergent viruses, risking biased surveillance, modeling, and risk assessment.

  • Open Access

    Sarand: exploring antimicrobial resistance gene neighbourhoods in complex metagenomic assembly graphs

    by Somayeh Kafaie, Shahlla Naseri, David B J Mahoney, Travis Gagie, Robert G Beiko, Finlay Maguire

    Antimicrobial resistance (AMR) is a major global challenge to human and animal health. The genomic element (e.g. chromosome, plasmid, and genomic islands) and neighbouring genes associated with an AMR gene play a major role in its function, regulation, evolution, and propensity to undergo lateral gene transfer. Therefore, characterizing these genomic contexts is vital for effective AMR surveillance, risk assessment, and stewardship. Metagenomic sequencing is widely used to identify AMR genes in microbial communities but fragmentary short-read data do not directly provide this critical contextual information. Assembly of these reads provides some contextual information but fails to recover many mobile genetic elements. Here, we introduce Sarand, a method retaining some of the sensitivity of read-based methods while providing the genomic context of assembly by extracting AMR genes and their associated context directly from metagenomic assembly graphs. Sarand uses BLAST-based homology searches with coverage statistics to identify and visualize AMR gene contexts while filtering false chimeric contexts. Using both real and simulated metagenomic data, we show that Sarand outperforms metagenomic assembly and other recently developed graph-based tools in terms of precision and sensitivity for this problem. Sarand enables effective extraction of metagenomic AMR gene contexts to better characterize AMR evolutionary dynamics within complex microbial communities.

  • Open Access

    Analysing antimicrobial resistance mobility patterns using a diverse dataset of over 8000 bacterial species

    by Baofeng Jia, Brian P. Alcock, Amogelang R. Raphenya, Jason Spence, Finlay Maguire, Robert G. Beiko, Andrew G. McArthur, Claire Bertelli, Fiona S.L. Brinkman

    2. Advances in genomics have enhanced surveillance of antimicrobial resistance (AMR), yet the factors governing resistance gene mobility, and therefore their risk of spread, remain poorly characterized. Here, we analyzed AMR gene distributions across thousands of bacterial genomes from NCBI RefSeq, encompassing clinical, agricultural and environmental isolates, to quantify associations with plasmids and predicted mobile genomic islands. AMR genes were identified using the Resistance Gene Identifier, and in addition to plasmid identification, mobile chromosomal elements were predicted using IslandViewer 4. Analysing both the full dataset and subsets of data with corrections for sampling bias, we show that known AMR genes are significantly enriched in mobile regions overall. However, stratification by resistance mechanism supported marked heterogeneity: certain drug classes and mechanisms are strongly associated with mobile elements, whereas others are predominantly chromosomal and non-mobile. Notably, mechanisms with specialized functions showed higher mobility, consistent with their role as “ecological public goods” that need not be present in all cells to confer community-level benefit. Differences were also observed across bacteria with distinct cell envelope structures. Together, these findings lay the groundwork for predictive models of AMR gene mobility and provide a framework for incorporating gene-level mobility into AMR risk assessment and antimicrobial stewardship policy. 3. Impact statement: Understanding which antimicrobial resistance (AMR) genes are most likely to spread is central to managing resistance in clinical, agricultural, and environmental settings. This study reports a large-scale, systematic analysis of antimicrobial resistance (AMR) gene mobility across >8000 bacterial species, spanning diverse clinical and other ecological sources. By linking resistance mechanisms to their genomic location (plasmids, genomic islands, or the rest of chromosomes), our study demonstrates that AMR genes are overall enriched in mobile elements, but that mobility varies substantially by mechanism and bacterial context. In particular, functionally specialized resistance mechanisms are more frequently associated with mobile elements, consistent with an “ecological public goods” model for AMR dissemination. These findings extend beyond gene-specific case studies to identify generalizable patterns that help explain why some resistance determinants spread more readily than others. The breadth of relevance spans clinical microbiology, evolutionary biology, environmental microbiology, agri-foods, and public health. The work provides evidence supporting an improved framework for AMR mobility risk assessment, and antimicrobial stewardship strategies, with direct implications for forecasting the durability of existing and future antibiotics. 4. Data summary: The complete dataset and analysis code used to generate the results can be accessed via the Open Science Framework (OSF) repository under DOI:10.17605/OSF.IO/WE3TX

  • Open Access

    Genomic, antigenic and transmission dynamics of influenza A(H3N2) subclade K in Canada, early 2025/26 season

    by George S. Long, Thomas W.A. Braukmann, Nicholas Waglechner, Patryk Aftanas, Alex Marchand-Austin, Julianne V. Kus, Shawn T. Clark, Kevin Katz, Maan Hasso, Finlay Maguire, et al.

    Influenza A(H3N2) subclade K virus was detected in Canada early in the 2025/26 influenza season, bearing an antigenic transition in the hemagglutinin (HA) glycoprotein. Analysis of 396 HA sequences from Canada showed antigenic divergence from 2025/26 influenza vaccine strains, consistent with partial mismatch. Phylodynamic analysis revealed sustained pre-vaccine transmission without clear post-vaccine expansion. Phylogenetic and phylogeographic analyses indicated interprovincial mixing within a highly connected metapopulation, highlighting the value of genomic surveillance for real-time epidemiologic inference and public health decision-making.


  • Open Access

    Best of Both Worlds? Optimising Graph-Based Antimicrobial Resistance Gene Profiling in Long and Short-Read Metagenomes

    by David Burke James Mahoney, Finlay Maguire

    Environmental surveillance using metagenomic sequencing offers a powerful way to track emerging and mobile antimicrobial resistance (AMR) genes and inform public health mitigation strategies. Read-based analysis tools can sensitively detect AMR genes in metagenomes but provide little information about the surrounding genome. This prevents easily linking detected genes with particular host species or mobile genetic elements. On the other hand, contig-based analysis tools can provide this genomic context but systematically fail to recover many AMR genes. Querying the intermediate assembly graph directly may provide a trade-off between these strengths and weaknesses. However, many existing tools capable of querying assembly graphs are designed for applications other than gene detection such as pan-genomics, indexing, or scaffolding. Therefore, a comprehensive evaluation of six tools across four search paradigms was performed to determine the optimal graph querying tool for profiling AMR genes in both long and short-read metagenomic assembly graphs. Across mock and simulated metagenomes of varying complexity and read-type, BLAST-based graph alignment (as implemented by GraphAligner) consistently outperformed other graph alignment algorithms. Overall, graph-based methods correctly identified 21% to 46% more AMR genes in complex datasets than contig analyses; however, increases in recall were modest. Combining assembly graphs analyses with contig-based analyses identifies up to 56% additional AMR genes across both long and short-read datasets. This study highlights the challenges associated with metagenomic AMR surveillance and demonstrates that graph-based analyses offer a useful tool in maximising sensitive identification of AMR genes and their genomic context from these data.

  • Open Access

    Evaluation of Phenotypic and Genotypic Susceptibility Testing Methods for Newer β-lactam/β-lactamase Inhibitor Combinations in Multidrug Resistant Pseudomonas aeruginosa

    by Clayton W Hall, Nicholas Waglechner, Erin Choi, Patryk Aftanas, Kevin Katz, Christie Vermeiren, Finlay Maguire, Robert Kozak, Xena X Li

    Background: Ceftazidime-avibactam (CZA), ceftolozane-tazobactam (CT), and imipenem-relebactam (IMR) are newer β-lactam/β-lactamase inhibitor (BL/BLI) combinations used for treatment of multidrug resistant (MDR) Pseudomonas aeruginosa, although resistance has already emerged. Optimal use of these agents relies on timely, accurate susceptibility testing results and understanding of local resistance mechanisms. Methods: 183 MDR P. aeruginosa clinical isolates were used to evaluate the performance of commercial Sensititre and Phoenix panels for CZA, CT, and IMR susceptibility testing compared to broth microdilution (BMD). Genomic resistance determinants were also predicted for each isolate with AMRFinderPlus. Results: Categorical agreement (CA) of the Sensititre panel compared to BMD was 95.8%, 90.1%, and 95.8% for CZA, CT, and IMR, respectively. CA of the Phoenix panel was 83.0% for CZA and 85.7% for CT. The Phoenix panel was biased toward under-calling CZA resistance while error rates were acceptable for CT by the error-rate-bound method. AMRFinderPlus identified acquired β-lactamases in 4.6% of first-time patient isolates. CA of genotype with BMD was 74.9% for CZA, 91.9% for CT, and 90.7% for IMR. However, all agents had unacceptably high VME rates using genotypic testing because many phenotypically resistant isolates had no identifiable genotypic resistance determinants. Conclusions: The Sensititre panel met standard acceptance criteria while the Phoenix panel had low CA for all tested BL/BLIs compared to BMD. Acquired β-lactamases were a rare cause of BL/BLI resistance. Further understanding of resistance mechanisms is required before phenotypic BL/BLI resistance can be reliably predicted from genotype, especially in settings where prevalence of acquired β-lactamases is low.


  • Open Access

    De Novo Genome Sequence Assembly of the RNAi-Tractable Paramecium bursaria 186b: An Endosymbiotic Model System

    by Guy Leonard, Benjamin H Jenkins, Fiona R Savory, Estelle S Kilias, Finlay Maguire, David S Milner, Thomas A Richards

    How two species engage in stable endosymbiosis is a biological quandary. The study of facultative endosymbiotic interactions has emerged as a useful approach to understand how endosymbiotic functions can arise. The ciliate protist Paramecium bursaria hosts green algae of the order Chlorellales in a facultative photo-endosymbiosis. We have recently reported RNAi as a tool for understanding gene function in P. bursaria 186b (CCAP strain 1660/18). To complement this work, here we report a near complete host genome and transcriptome sequence dataset, using both Illumina and PacBio sequencing methods, in order to aid genome analysis and to enable the design of RNAi experiments. Our analyses demonstrate P. bursaria 186b, like other ciliates such as diverse species of Paramecia, possess numerous tiny introns. These data patterns, combined with the alternative genetic code common to ciliates, make gene identification and annotation challenging; as such, we identify gene models using Iso-Seq methodologies. These data will aid the investigation of genome evolution in the Paramecia and provide additional source data for the exploration of endosymbiotic functions.


  • Open Access

    CARD k-mers: Unmasking the pathogen hosts and genomic contexts of antimicrobial resistance genes in metagenomic sequences

    by Mateusz A. Wlodarski, Tammy T. Y. Lau, Brian P. Alcock, Amogelang R. Raphenya, Tiffany E. Ta, Finlay Maguire, Robert G. Beiko, Andrew G. McArthur

    Antimicrobial resistance (AMR) is a global health crisis requiring rapid surveillance across human, agricultural, and environmental systems. A major challenge during outbreaks is not only detecting antimicrobial resistance genes (ARGs), but also unmasking their pathogen hosts and genomic context, as ARGs alone do not fully capture AMR risk. Pathogen identification is often essential for guiding effective treatment. While culture-based methods remain the diagnostic gold standard, they are slow and sometimes impractical. Faster metagenomic (mNGS) tools typically detect either ARGs, taxonomy, or genomic context, but rarely all three, resulting in fragmented surveillance. Existing k-mer classifiers like Kraken2 and CLARK, designed for general taxonomy, often perform poorly on AMR-specific sequences. We introduce CARD k-mers, the first tool built to jointly predict species-level taxonomy and genomic context (plasmid vs. chromosome) for ARGs in short metagenomic reads. Integrated with the Comprehensive Antibiotic Resistance Database (CARD), CARD k-mers enables rapid, context-aware assignment of ARGs to their likely pathogen and genomic element origin. In benchmarking with 103,456 in- silico pathogen-specific AMR alleles, CARD k-mers outperformed Kraken2 and CLARK by 10.85% and 15.2%, respectively, and correctly classified the genomic context of 4,590 chromosome- and 176 plasmid-specific ARGs. The tool operates at speeds exceeding 675,000 metagenomic reads per minute. By delivering fast, accurate, and context-rich classification of ARGs, CARD k-mers significantly advances untargeted AMR surveillance and is accessible to users with basic command-line experience for use in both clinical and environmental pipelines. CARD k-mers is available at: https://github.com/arpcard/rgi .


  • Open Access

    Functional and Structural Characterization of Treatment-Emergent Nirmatrelvir Resistance Mutations at Low Frequencies in the Main Protease (Mpro) Reveals a Unique Evolutionary Route for SARS-CoV-2 to Gain Resistance

    by Natalie M Deschenes, Jimena Pérez-Vargas, Zoe Zhong, Merrilee Thomas, Calem Kenward, Wesley A Mosimann, Liam J Worrall, Nicholas Waglechner, Angel XinLiu Li, Finlay Maguire, et al.

    Background: The main protease (Mpro) is one of the most attractive targets for antiviral drug discovery against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Mutations in Mpro have been linked to resistance against nirmatrelvir-ritonavir (NIR-RIT), an important therapy for SARS-CoV-2 infection. This study aimed to identify low-frequency antiviral resistance mutations in Mpro from NIR-RIT–treated patients and to analyze the enzymatic properties, inhibitor susceptibility, and structural features of new Mpro clinical variants. Methods: We screened 1528 SARS-CoV-2–positive patients from 2 hospitals and identified 17 who remained positive after treatment. Whole-genome sequencing of nasopharyngeal specimens was conducted to identify Mpro clinical variants. The impact of these mutations on Mpro activity and inhibitor susceptibility was investigated using a fluorescent enzymatic biosensor in human cells, along with in vitro thermal stability and structure-based analyses of the Mpro mutants and Mpro-NIR complexes. Results: The analysis identified 2 novel Mpro clinical variants: D48D/L58F/P132H (variant 1) and D48D/L67V/K90R/P132H (variant 2). Our data show that the selected clinical mutations are localized in the Mpro N-terminal domain, are far from the catalytic site, and strongly impact NIR resistance without affecting Mpro activity. Structural analysis and thermal denaturation analyses revealed that these mutations may disrupt the substrate binding site's structure and dynamics, reducing protein stability and potentially impacting substrate binding or dimerization without compromising catalytic activity. Conclusions: Our new Mpro clinical mutations that confer complete resistance to NIR were not identified during previous cell-culture-based studies. More research is needed to explore resistance mechanisms, providing insights into strategies that mitigate resistance and protect therapeutic efficacy.